Universe Pharmaceuticals (UPC) Short term Debt: 2020-2024
- Universe Pharmaceuticals' Short term Debt rose 6.83% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.9 million, marking a year-over-year increase of 6.83%. This contributed to the annual value of $5.9 million for FY2024, which is 6.83% up from last year.
- As of Q3 2024, Universe Pharmaceuticals' Short term Debt stood at $5.9 million, which was up 6.19% from $5.5 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Short term Debt registered a high of $956.5 billion during Q3 2020, and its lowest value of $7,293 during Q1 2022.
- In the last 3 years, Universe Pharmaceuticals' Short term Debt had a median value of $5.5 million in 2023 and averaged $4.3 million.
- As far as peak fluctuations go, Universe Pharmaceuticals' Short term Debt slumped by 100.00% in 2021, and later surged by 74,528.34% in 2023.
- Quarterly analysis of 5 years shows Universe Pharmaceuticals' Short term Debt stood at $956.5 billion in 2020, then crashed by 100.00% to $19,723 in 2021, then soared by 17,033.62% to $3.4 million in 2022, then spiked by 62.24% to $5.5 million in 2023, then rose by 6.83% to $5.9 million in 2024.
- Its Short term Debt was $5.9 million in Q3 2024, compared to $5.5 million in Q1 2024 and $5.5 million in Q3 2023.
